The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share. The clinical stage biotech ...
News
- Acceleron: Q2 Earnings Snapshot
- 22nd Century: Q2 Earnings Snapshot
The plant biotechnology company posted revenue of $8.4 million in the period. The company's shares closed at $2.99. A year ago, they were trading ...
- Puma Biotechnology, Inc. (PBYI) CEO Alan Auerbach on Q2 2021 Results - Earnings Call Transcript
These data sets were also discussed and well represented at San Antonio Breast Conference Symposium and the Miami Breast Cancer Conference, ...
- Aurinia: Q2 Earnings Snapshot
The biotechnology company posted revenue of $6.6 million in the period, which topped Street forecasts. Five analysts surveyed by Zacks expected $5 ...
- Study shows too much coffee could shrink your brain
Author: Lachlan Van Schaik, PhD candidate, School of Pharmacy and Biomedical Sciences, La Trobe University. This article is republished from The ...